OTC

Strength

12.5; 1; 30 mg/5mL; mg/5mL; mg/5mL

NDC

12830076216

Classification

Generic

Dosage Form

LIQUID

Route

ORAL

Last Updated

1/22/2020

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

10/1/2013

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

0.0%

5Y

0.0%

All

+9.9%

Generic Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.